Health Policy and Management, University of Minnesota, USA Medtronic Neuromodulation, Minneapolis, USA Department of Molecular Medicine & Surgery, Karolinska Institute, Stockholm, Sweden Department of Neurosurgery, Karolinska University Hospital, Stockholm, Sweden University of Washington School of Medicine, Seattle, USA Peninsula Medical School, Universities of Exeter & Plymouth, UK.
Pain. 2010 May;149(2):338-344. doi: 10.1016/j.pain.2010.02.034. Epub 2010 Mar 15.
Patients with neuropathic pain (NeuP) experience substantially lower health-related quality of life (HRQoL) than the general population. The aim of this systematic review and meta-analysis is to test the hypothesis that NeuP is associated with low levels of health utility. A structured search of electronic databases (MEDLINE, EMBASE, Cochrane Library and CINAHL) was undertaken. Reference lists of retrieved reports were also reviewed. Studies reporting utility single-index measures (preference based) in NeuP were included. Random effects meta-analysis was used to pool EQ-5D index utility estimates across NeuP conditions. The association of utilities and pre-defined factors (NeuP condition, patient age, sex, duration and severity of pain and method of utility scoring) was examined using meta-regression. Twenty-four studies reporting health utility values in patients with NeuP were included in the review. Weighted pooled utility score across the studies varied from a mean of 0.15 for failed back surgery syndrome to 0.61 for post-herpetic neuralgia and diabetic neuropathy. Although there was substantial heterogeneity (P<0.0001) across studies, we found little variation in utility as a function of patient and study characteristics. The single exception was a significant relationship (P<0.0001) between increasing neuropathic pain severity and a reduction in utility. This study confirms the hypothesis that patients with NeuP experience low utilities and therefore low HRQoL. However, the contribution of non-NeuP co-morbidity remains unclear. Neuropathic pain severity emerged as a primary predictor of the negative health impact of NeuP.
患有神经性疼痛(NeuP)的患者的健康相关生活质量(HRQoL)明显低于一般人群。本系统评价和荟萃分析的目的是检验假设,即 NeuP 与低水平的健康效用有关。对电子数据库(MEDLINE、EMBASE、Cochrane Library 和 CINAHL)进行了结构化搜索。还审查了检索报告的参考文献列表。报告了在 NeuP 中使用单一效用指标(基于偏好)的研究被纳入。使用随机效应荟萃分析来汇总 NeuP 条件下的 EQ-5D 指数效用估计值。使用荟萃回归检验效用与预定义因素(NeuP 状况、患者年龄、性别、疼痛持续时间和严重程度以及效用评分方法)之间的关联。共有 24 项研究报告了患有 NeuP 的患者的健康效用值,这些研究被纳入了综述。研究中加权的总体效用评分从失败的背部手术综合征的平均 0.15 到疱疹后神经痛和糖尿病神经病变的 0.61 不等。尽管研究之间存在很大的异质性(P<0.0001),但我们发现效用随患者和研究特征的变化很小。唯一的例外是神经病理性疼痛严重程度与效用降低之间存在显著关系(P<0.0001)。这项研究证实了这样的假设,即患有 NeuP 的患者体验到低效用,因此具有低的 HRQoL。然而,非 NeuP 合并症的贡献仍不清楚。神经病理性疼痛严重程度是 NeuP 对健康产生负面影响的主要预测因素。
Health Technol Assess. 2024-10
Cochrane Database Syst Rev. 2021-4-19
Cochrane Database Syst Rev. 2017-12-2
Cochrane Database Syst Rev. 2016-7-28
Cochrane Database Syst Rev. 2020-1-9
Cochrane Database Syst Rev. 2017-6-28
Cochrane Database Syst Rev. 2017-1-13
Cochrane Database Syst Rev. 2017-9-14
Cochrane Database Syst Rev. 2017-6-15
Ont Health Technol Assess Ser. 2024-12-3